文献速递鼻科睡眠呼吸障碍

鼻窦结局测试的睡眠子域作为慢性鼻窦炎患者睡眠呼吸暂停的潜在筛查工具

Sleep Subdomain of the Sinonasal Outcome Test as a Potential Screening Tool for Sleep Apnea in Chronic Rhinosinusitis.
PubMed 文献 · Laryngoscope · 2023-05-09

本研究回顾性纳入2012至2021年接受内镜鼻窦手术的慢性鼻窦炎患者109例,比较伴与不伴阻塞性睡眠呼吸暂停患者的睡眠子域SNOT-22评分,并评估其筛查效能。结果显示合并OSA患者睡眠子域评分更高,评分17.5时敏感度68.9%、特异度55.7%、诊断准确率63%。作者认为评分≥17.5应提示进一步评估OSA。

要点

  • 慢性鼻窦炎合并OSA患者睡眠子域SNOT-22评分高于非OSA患者。
  • 睡眠子域评分17.5筛查OSA的敏感度68.9%、特异度55.7%、准确率63%。
  • 作者认为评分≥17.5应提示进一步评估OSA,可考虑作为替代筛查工具。

核心结论

  • 慢性鼻窦炎合并OSA患者的睡眠子域SNOT-22评分更高,该评分对OSA筛查具有较高的敏感度、特异度和准确率。
  • 作者认为睡眠子域评分≥17.5应提示进一步评估OSA,在其他经验证工具未使用时,可考虑作为替代OSA筛查工具。

研究设计与样本

  • 回顾性病历审查,纳入2012至2021年因慢性鼻窦炎接受内镜鼻窦手术的患者109例。
  • 纳入患者为已报告OSA诊断并完成SNOT-22者,或OSA状态未记录但完成STOP-BANG和SNOT-22者。
  • 收集人口学资料、问卷评分和OSA状态,采用受试者工作特征曲线评估睡眠子域SNOT-22的截断值、敏感度和特异度。
  • 证据等级为回顾性病历审查,Level 3。

主要发现

  • 109例患者中41%合并OSA。
  • OSA患者体质指数高于非OSA患者(32.1 ± 7.7 vs. 28.35 ± 6.7 kg/m2,p = 0.02)。
  • OSA患者睡眠子域SNOT-22评分高于非OSA患者(21.96 ± 12.1 vs. 16.8 ± 11.2,p = 0.021)。
  • OSA患者STOP-BANG评分高于非OSA患者(3.1 ± 1.44 vs. 2.06 ± 1.27,p = 0.038)。
  • 睡眠子域SNOT-22评分17.5用于检测OSA的敏感度为68.9%、特异度为55.7%、诊断准确率为63%(p = 0.022)。

关键数值与推荐

  • 睡眠子域SNOT-22评分17.5筛查OSA:敏感度68.9%、特异度55.7%、诊断准确率63%(p = 0.022)。
  • 作者认为睡眠子域SNOT-22评分≥17.5应提示进一步评估OSA。
  • 作者认为在其他经验证工具未使用时,可考虑将睡眠子域SNOT-22作为替代OSA筛查工具。

临床怎么用

  • 对慢性鼻窦炎患者可关注睡眠子域SNOT-22评分,作者认为评分≥17.5应提示进一步评估OSA。
  • 作者认为在其他经验证OSA筛查工具未使用时,可考虑将睡眠子域SNOT-22作为替代筛查工具。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Approximately 20% of patients with chronic rhinosinusitis (CRS) have comorbid obstructive sleep apnea (OSA). Patients with undiagnosed OSA are at high risk for perioperative complications. The Sinonasal Outcomes Test (SNOT-22) Questionnaire is commonly administered to CRS patients, whereas OSA screening tools are less routinely employed. This study compared SNOT-22 sleep subdomain (Sleep-SNOT) scores among non-OSA CRS versus OSA-CRS patients undergoing ESS, and assessed sensitivity, specificity, and diagnostic accuracy of the Sleep-SNOT for OSA screening. METHODS: Retrospective review of patients that underwent endoscopic sinus surgery (ESS) for CRS from 2012 to 2021. Patients either carried a reported OSA diagnosis and completed the SNOT-22, or had undocumented OSA status and completed both STOP-BANG and SNOT-22. Demographics, questionnaire scores, and OSA status were collected. A receiver operating characteristic (ROC) curve assessed cutoff scores, sensitivity, and specificity of the Sleep-SNOT for OSA screening. RESULTS: Of 600 patients reviewed, 109 were included. 41% had comorbid OSA. OSA patients had a higher BMI (32.1 ± 7.7 vs. 28.35 ± 6.7 kg/m2 ; p = 0.02), Sleep-SNOT (21.96 ± 12.1 vs. 16.8 ± 11.2; p = 0.021) and STOP-BANG (3.1 ± 1.44 vs. 2.06 ± 1.27; p = 0.038) scores. A Sleep-SNOT score of 17.5 had a sensitivity of 68.9%, specificity of 55.7%, and diagnostic accuracy of 63% for OSA detection (p = 0.022). CONCLUSIONS: Sleep-SNOT scores are greater for CRS-OSA patients. The Sleep-SNOT ROC curve demonstrates a high sensitivity, specificity, and accuracy for OSA screening in CRS patients. A Sleep-SNOT score of ≥17.5 should prompt further OSA evaluation. The Sleep-SNOT may be considered as a surrogate OSA screening tool when other validated tools are not employed. LEVEL OF EVIDENCE: Retrospective chart review, Level 3 Laryngoscope, 133:2029-2034, 2023.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Duffy AN, Alapati R, Chitguppi C, et al. Sleep Subdomain of the Sinonasal Outcome Test as a Potential Screening Tool for Sleep Apnea in Chronic Rhinosinusitis. Laryngoscope. 2023. PMID: 37159280. doi:10.1002/lary.30730

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。